Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Precision Biosciences (DTIL) Income from Continuing Operations (2018 - 2025)

Precision Biosciences (DTIL) has disclosed Income from Continuing Operations for 8 consecutive years, with 20002000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Income from Continuing Operations fell 1.18% to 20002000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was 86008000.0, a 676.32% decrease, with the full-year FY2024 number at 21181000.0, up 44.67% from a year prior.
  • Income from Continuing Operations was 20002000.0 for Q3 2025 at Precision Biosciences, up from 21119000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 25429000.0 in Q2 2024 to a low of 30714000.0 in Q4 2021.
  • A 5-year average of 11192578.95 and a median of 13909000.0 in 2022 define the central range for Income from Continuing Operations.
  • Peak YoY movement for Income from Continuing Operations: surged 1564.8% in 2024, then plummeted 582.47% in 2025.
  • Precision Biosciences' Income from Continuing Operations stood at 30714000.0 in 2021, then skyrocketed by 161.93% to 19020000.0 in 2022, then crashed by 171.72% to 13642000.0 in 2023, then tumbled by 74.05% to 23744000.0 in 2024, then increased by 15.76% to 20002000.0 in 2025.
  • Per Business Quant, the three most recent readings for DTIL's Income from Continuing Operations are 20002000.0 (Q3 2025), 21119000.0 (Q2 2025), and 21143000.0 (Q1 2025).